Lumeblue (previously known as Methylthioninium chloride Cosmo) Evropska unija - švedščina - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - metyltioniniumklorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Phenylephrine hydrochloride Bausch & Lomb 10 % (100 mg/ml) Ögondroppar, lösning i endosbehållare Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

phenylephrine hydrochloride bausch & lomb 10 % (100 mg/ml) ögondroppar, lösning i endosbehållare

bausch & lomb ireland limited - fenylefrinhydroklorid - Ögondroppar, lösning i endosbehållare - 10 % (100 mg/ml) - fenylefrinhydroklorid 100 mg aktiv substans; natriummetabisulfit hjälpämne - fenylefrin

Miflonide 200 mikrogram Inhalationspulver, hård kapsel Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

miflonide 200 mikrogram inhalationspulver, hård kapsel

novartis sverige ab - budesonid - inhalationspulver, hård kapsel - 200 mikrogram - laktosmonohydrat hjälpämne; sojalecitin hjälpämne; budesonid 200 mikrog aktiv substans - budesonid

Miflonide 400 mikrogram Inhalationspulver, hård kapsel Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

miflonide 400 mikrogram inhalationspulver, hård kapsel

novartis sverige ab - budesonid - inhalationspulver, hård kapsel - 400 mikrogram - sojalecitin hjälpämne; budesonid 400 mikrog aktiv substans; nykockin hjälpämne; laktosmonohydrat hjälpämne - budesonid

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Evropska unija - švedščina - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydroklorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 och 5. 1 för tillgänglig data på olika kombinationer).

Calmolan 0,26 mg Depottablett Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

calmolan 0,26 mg depottablett

g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 0,26 mg - pramipexoldihydrokloridmonohydrat 0,375 mg aktiv substans - pramipexol

Pramipexole Hexal 0,26 mg Depottablett Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

pramipexole hexal 0,26 mg depottablett

hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 0,26 mg - pramipexoldihydrokloridmonohydrat 0,375 mg aktiv substans - pramipexol

Calmolan 0,52 mg Depottablett Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

calmolan 0,52 mg depottablett

g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 0,52 mg - pramipexoldihydrokloridmonohydrat 0,75 mg aktiv substans - pramipexol

Pramipexole Hexal 0,52 mg Depottablett Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

pramipexole hexal 0,52 mg depottablett

hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 0,52 mg - pramipexoldihydrokloridmonohydrat 0,75 mg aktiv substans - pramipexol

Calmolan 1,05 mg Depottablett Švedska - švedščina - Läkemedelsverket (Medical Products Agency)

calmolan 1,05 mg depottablett

g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 1,05 mg - pramipexoldihydrokloridmonohydrat 1,5 mg aktiv substans - pramipexol